| Literature DB >> 21139846 |
Yoel Kashman1, Ashgan Bishara, Maurice Aknin.
Abstract
A large variety of uniqueEntities:
Keywords: Fascaplysinopsis sp.; heterocycles; leukemia cells; marine invertebrates; nitrogenous macrolide
Mesh:
Substances:
Year: 2010 PMID: 21139846 PMCID: PMC2996178 DOI: 10.3390/md8112810
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1An assembly of unique marine alkaloids isolated by us.
Figure 2Cyclic hexapeptides isolated from Didemnum molle.
Scheme 1Biomimetic two steps synthesis of eilatin.
Scheme 2Tautomers of violatinctamine.
Figure 3Callynormine A, a new type of cyclic peptide.
Scheme 3Suggested biogenesis of the endiamino bond and the synthesis of an endiamino cyclichexapeptide.
Scheme 4The synthesis of cyclic endiamino and thioenamino peptides.
Figure 4The structure of salaramide A and B (the 15-homologe).
Figure 5The structure of plakinamine A.
Figure 6The structure of saldedines A and B (10-OH).
Figure 7The structure of njaoamine G and H (9-OH) and 4-quinolone.
Figure 8The structures of nuttingins A–F and malonganenones D–H.
Figure 9The structure of Haliclona tulearensis N-atom containing metabolites.
Figure 10Salarins, tulearins, taumycins and tausalarins, four new groups of metabolites from the Madagascr sponge Fascaplysinopsis sp.
Figure 11The ten Fascaaplysinopsis sp. salarins (A–J).
Figure 13COSY (—), and key 13 CH- and 15NH-HMBC correlations of salarin C.
Figure 12Wire frame model and ORTEP representation of salarin A, obtained by X-ray diffraction analysis.
Scheme 5Suggested biogenetic of the oxazole ring of salarin C [63].
Scheme 6Suggested biogenetic transformations of salarin C to salarins A, B and D.
Figure 14Transformations of salarin A and/or C.
Figure 15The structures of tulearins A–C, the cyclic 8,9-carbonate and MTPA-ester derivative.
Figure 16The structure of taumycin A and B and 2D correlations for taumycin A.
Figure 17The structure of tausalarin C and connecting key 2D NMR correlations.
Scheme 7Suggested biogenesis on tausalarin C.